Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
about
Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Poor Long-Term Efficacy of Pre ...... occal-Specific Antibody Titers
@ast
Poor Long-Term Efficacy of Pre ...... occal-Specific Antibody Titers
@en
type
label
Poor Long-Term Efficacy of Pre ...... occal-Specific Antibody Titers
@ast
Poor Long-Term Efficacy of Pre ...... occal-Specific Antibody Titers
@en
prefLabel
Poor Long-Term Efficacy of Pre ...... occal-Specific Antibody Titers
@ast
Poor Long-Term Efficacy of Pre ...... occal-Specific Antibody Titers
@en
P2093
P2860
P1433
P1476
Poor Long-Term Efficacy of Pre ...... occal-Specific Antibody Titers
@en
P2093
Biree Andemariam
Christina Cotte
Dennis W Metzger
Eric R Secor
Kara Rogers
Roger S Thrall
Sharon Salmon
Sonali J Bracken
Steven M Szczepanek
P2860
P304
P356
10.1371/JOURNAL.PONE.0149261
P407
P577
2016-02-24T00:00:00Z